U.S. Patent Disclosures
Wednesday, January 19, 2011
Omni Bio Pharmaceutical Inc., of Denver, has received U.S. Patent No. 7,807,781 titled "Inhibitors of Serine Protease Activity and Their Use in Methods and Compositions for Treatment of Viral Infections."
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.